Overview of Aboriginal and Torres Strait Islander health status, 2017

Australian Indigenous HealthInfoNet, Last updated: 15 June 2018

The Overview of Aboriginal and Torres Strait Islander health status  aims to provide a comprehensive summary of the most recent indicators of the health and current health status of Australia’s Aboriginal and Torres Strait Islander people.

The initial sections of the Overview provide information about the context of Aboriginal and Torres Strait Islander health, population, and various measures of population health status. The remaining sections are about selected health conditions and risk and protective factors that contribute to the overall health of Aboriginal and Torres Strait Islander people. These sections comprise an introduction and evidence of the extent of the condition or risk/protective factor.

The annual Overview is a resource relevant for workers, students and others who need to access up-to-date information about Aboriginal and Torres Strait Islander health.

Accompanying the Overview is a set of PowerPoint slides designed to help lecturers and others provide up-to-date information.

Australia’s health 2018 (Report)

Australian Institute of Health and Welfare,  Release Date: 

 

Australia’s Health 2018 is the AIHW’s 16th biennial report on the health of Australians. It examines a wide range of contemporary topics in a series of analytical feature articles and short statistical snapshots.

The report also summarises the performance of the health system against an agreed set of indicators.

Australia’s health 2018: in brief is a companion report to Australia’s health 2018.

Table of contents:

Whole report:

PDF Report (17.3Mb)

Australia’s health 2018 in brief:

Companion ‘in brief’ booklet presents highlights in a compact easy-to-use format.

 

Sex without fear – ​my experiment with ​the HIV-prevention drug PrEP

The Guardian, Thursday 22 June 2017 

When I first heard about the HIV-prevention drug PrEP – pre-exposure prophylaxis – I had mixed feelings.  It remains controversial even among readers of the gay magazine Attitude. “Why should my taxes pay for these sluts to have bareback sex?” is a typical comment. But I was worried that my reaction was the result of anti-gay conditioning, being brought up to think that I didn’t deserve the same rights as the rest of society, and I wanted to challenge this by taking the drug for three months to find out more.

 

Two-drug HIV therapy just as effective as three-drug therapy

aidsmap/nam, 25 October 2016

SImplification of an antiretroviral treatment to a boosted protease inhibitor and the nucleoside analogue lamivudine (a dual regimen) is highly effective in people switching from a stable three-drug regimen, researchers reported on Monday at the International Congress on Drug Therapy in HIV Infection (HIV Glasgow).

Read more here 

PEP after Non-Occupational and Occupational Exposure to HIV: Australian Guidelines revised

Our apologies to those who tried to access SASHA while it was down. The technical difficulties have now been resolved.

——————————————————————————————————————–

Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine, August 2016

The Second edition of the Post-Exposure Prophylaxis after Non-Occupational and Occupational Exposure to HIV: Australian National Guidelines is now available.

These guidelines outline the management of individuals who have been exposed (or suspect they have been exposed) to HIV in non-occupational and occupational settings.

There are currently no data from randomised controlled trials of the use of post-exposure prophylaxis (PEP) and evidence for use has been extrapolated from animal data, mother to child transmission, occupational exposure and small prospective studies of PEP regimens in HIV-negative men. Accordingly, assumptions are made about the direction of management.

Every presentation for PEP should be assessed on a case-by-case basis, balancing the potential harms and benefits of treatment.

Recommendations following non-occupational exposure have been updated, and information about PEP in the context of pre-exposure prophylaxis (PrEP), PEP and children, renal disease, and gender identity and history has been added.

  • Download the revised guidelines (PDF) here
  • Updates to the supplementary documents, as well as a navigable website for the guidelines, will soon be available. At present, the 2013 literature review and checklist are still available, linked below:

    PEP Checklist (2013)

    Literature Review (2013)

 

HIV infection associated with an increased risk of the diseases of ageing

nam, 24 September 2014

HIV infection is associated with an increased risk of several diseases of old age, according to Dutch research published in the online edition of Clinical Infectious Diseases.

Read more